Cytokine regulation of the macrophage (Mφ) system studied using the colony stimulating factor-1-deficient op/op mouse

Physiological Reviews

Volumn 76, Issue 4, 1996, Pages 927-947

  Wiktor Jedrzejczak, Wieslaw ^a   Gordon, Siamon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; ATHEROGENESIS; CELL DIFFERENTIATION; DENDRITE; GROWTH REGULATION; HEMATOPOIESIS; HISTIOCYTE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; KUPFFER CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE FUNCTION; MICROGLIA; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0029859536     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.1996.76.4.927     Document Type: Article

References (158)

1. ACTON, S. L., P. E. SCHERER, H. F. LODISH, AND M. KRIEGER. Expression cloning of SR-B1, a CD36-related class B scavenger receptor. J. Biol. Chem. 269: 21003-21009, 1994.
2. ADAMS, D. O., AND T. A. HAMILTON. Molecular basis of Mφ activation: diversity and its origins. In: The Natural Immune System: The Mφ, edited by C. E. Lewis and J. O. D. McGee. Oxford, UK: IRL, 1992, p. 75-114.
3. AUGER, M. J. Mononuclear phagocytes. Br. Med. J. 298: 546-548, 1989.
4. AUGER, M. J., AND J. A. ROSS. The biology of the Mφ. In: The Natural Immune System: The Mφ, edited by C. E. Lewis and J. O. D. McGee. Oxford, UK: IRL, 1992, p. 2-74.
5. BAGBY, G. C., JR., C. A. DINARELLO, P. WALLACE, C. WAGNER, S. HEFENEIDER, AND E. MCCALL. Interleukin 1 stimulates granulocyte Mφ colony stimulating activity release by vascular endothelial cells. J. Clin. Invest. 78: 1316-1323, 1986.
6. BARTELMEZ, S. H., AND E. R. STANLEY. Synergism between hemopoietic growth factors (HGFs) detected by their effects on cells bearing receptors for a lineage specific HGF: assay for hemopoietin-1. J. Cell. Physiol. 122: 370-378, 1985.
7. BARTOCCI, A., D. S. MASTROGIANNIS, G. MIGLIORATI, R. J. STOCKERT, A. W. WOLKOFF, AND E. R. STANLEY. Mφ specifically regulates the concentration of their own growth factor in the circulation. Proc. Natl. Acad. Sci. USA 84: 6179-6183, 1987.
8. BEGG, S. K., AND I. BERTONCELLO. The hematopoietic deficien cies in osteopetrotic (op/op) mice are not permanent, but progressively correct with age. Exp. Hematol. 21: 493-495, 1993.
9. BEGG, S. K., J. M. RADLEY, J. W. POLLARD, O. T. CHISHOLM, E. R. STANLEY, AND I. BERTONCELLO. Delayed hematopoietic development in osteopetrotic (op/op) mice. J. Exp. Med. 177: 237-242, 1993.
10. BERTONCELLO, I., T. R. BRADLEY, G. S. HODGSON, AND J. M. DUMLOP. The resolution, enrichment, and organization of normal bone marrow high proliferative potential colony-forming cell subsets on the basis of rhodamine-123 fluorescence. Exp. Hematol. 19: 174-178, 1991.
11. BIRCHENALL-ROBERTS, M. C., C. FERRER, D. FERRIS, L. A. FALK, J. KASPER, G. WHITE, AND F. W. RUSCETTI. Inhibition of murine monocyte proliferation by a colony-stimulating factor-1 antisense oligodeoxynucleotide. Evidence for autocrine regulation. J. Immunol. 145: 3290-3296, 1990.
12. BOYCE, B. F., T. B. AUFDEMORTE, I. R. GARRETT, A. J. P. YATES, AND G. R. MUNDY. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125: 1142-1150, 1989.
13. BRADLEY, T. R., AND G. S. HODGSON. Detection of primitive Mφ progenitor cells in bone marrow. Blood 54: 1446-1450, 1979.
14. CECCHINI, M. G., M. G. DOMINGUEZ, S. MOCCI, A. WETTERWALD, R. FELIX, H. FLEISCH, O. CHISHOLM, W. HOFSTETTER, J. W. POLLARD, AND E. R. STANLEY. Role of colony stimulating factor-1 in the establishment and regulation of tissue Mφ during postnatal development of the mouse. Development 120: 1357-1372, 1994.
15. CHANG, M.-D. Y., E. R. STANLEY, H. KHALILI, O. CHISHOLM, AND J. W. POLLARD. Osteopetrotic (op/op) mice deficient in Mφ have the ability to mount a normal T-cell-dependent immune response. Cell. Immunol. 162: 146-152, 1995.
16. CHANG, Y., S. ALBRIGHT, AND F. LEE. Cytokines in the central nervous system: expression of Mφ colony stimulating factor and its receptor during development. J. Neuroimmunol. 52: 9-17, 1994.
17. CHEERS, C., A. M. HAIGH, A. KELSO, D. METCALF, E. R. STANLEY, AND A. M. YOUNG. Production of colony-stimulating factors (CSFs) during infection: separate determinations of Mφ-, granulocyte-, granulocyte-Mφ-, and multi-CSFs. Infect. Immun. 56: 247-251, 1988.
18. DALTON, D. K., S. PITTS-MEEK, S. KESHAV, I. S. FIGARI, A. BRADLEY, AND T. A. STEWART. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science Wash. DC 259: 1739-1742, 1993.
19. DE VILLIERS, W. J. S., I. P. FRASER, D. A. HUGHES, A. G. DOYLE, AND S. GORDON. M-CSF selectively enhances macrophage scavenger receptor expression and function. J. Exp. Med. 180: 705-709, 1994.
20. DE VILLIERS, W. J. S., I. P. FRASER, D. A. HUGHES, AND S. GORDON. Macrophage adhesion in atherosclerosis: a role for the scavenger receptor? Atherosclerosis X: 593-597, 1995.
21. DOHERTY, T. M., R. KASTELEIN, S. MENON, S. ANDRADE, AND R. L. COFFMAN. Modulation of murine Mφ function by IL-13. J. Immunol. 151: 7151-7160, 1993.
22. DRANOFF, G., A. D. CRAWFORD, M. SADELAlN, B. REAM, A. RASHID, R. T. BRONSON, G. R. DICKERSIN, C. J. BACHURSKI, E. L. MARK, J. A. WHITSETT, AND R. C. MULLIGAN. Involvement of granulocyte-Mφ colony-stimulating factor in pulmonary homeostasis. Science Wash. DC 264: 713-716, 1994.
23. FALK, L. A., AND S. N. VOGEL. Comparison of bone marrow progenitors responsive to granulocyte-Mφ colony stimulating factor and Mφ colony stimulating factor-1. J. Leukocyte Biol. 43: 148-157, 1988.
24. FELIX, R., M. G. CECCHINI, AND H. FLEISCH. Mφ colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127: 2592-2594, 1990.
25. FELIX, R., M. G. CECCHINI, W. HOFSTETTER, P. R. ELFORD, A. STUTZER, AND H. FLEISCH. Impairment of Mφ colony-stimulating factor production and lack of resident bone marrow Mφ in the osteopetrotic op/op mouse. J. Bone Miner. Res. 5: 781-789, 1990.
26. FELIX, R., W. HOFSTETTER, A. STUTZER, AND H. FLEISCH. Impairment of Mφ colony-stimulating factor (M-CSF) production in the osteopetrotic op/op mouse (Abstract). Calcif. Tissue Int. 42: 17, 1988.
27. FELIX, R., W. HOFSTETTER, A. WETTERWALD, M. G. CECCHINI, AND H. FLEISCH. Role of colony-stimulating factor-1 in bone metabolism. J. Cell. Biochem. 55: 340-349, 1994.
28. FIDLER, I. J., AND A. J. SCHROIT. Recognition and destruction of neoplastic cells by activated Mφ: discrimination of altered self. Biochim. Biophys. Acta 948: 151-173, 1988.
29. FRANZ, T. Immortalized fibroblastoid cells of osteopetrotic mutant mice (op/op) do not secrete CSF-1 and do not inhibit CSF-1 activity released by normal cells. Exp. Hematol. 19: 170-173, 1991.
30. FRASER, I., D. HUGHES, AND S. GORDON. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature Lond. 364: 343-346, 1993.
31. GASSON, J. C. Molecular physiology of granulocyte-Mφ colony-stimulating factor. Blood 77: 1131-1145, 1991.
32. GISSELBRECHT, S., B. SOLA, S. FICHELSON, D. BORDEREAUX, P. TAMBOURIN, M.-G. MATTEI, D. SIMON, AND J.-L. GUENET. The murine M-CSF gene is localized on chromosome 3. Blood 73: 1742-1746, 1989.
33. GOOD, R. A. Experiments of nature in the development of modern immunology. Immunol. Today 12: 283-286, 1991.
34. GORDON, S. Biology of the Mφ. J. Cell Sci. Suppl. 4: 267-286, 1986.
35. GORDON, S. Mononuclear phagocyte system and tissue homeostasis. In: Oxford Textbook of Medicine. Oxford, UK: Oxford Univ. Press, 1995, p. 84-95.
36. GORDON, S., S. CLARKE, D. GREAVES, AND A. DOYLE. Molecular immunobiology of Mφ: recent progress. Curr. Opin. Immunol. 7: 24-33, 1995.
37. HAMILTON, J. A. Colony stimulating factors, cytokines and monocyte-Mφ: some controversies. Immunol. Today 14: 18-24, 1993.
38. HARA, T., M. ICHIHARA, M. TAKAGI, AND A. MIYAJIMA. Interleukin-3 (IL-3) poor-responsive inbred mouse strains carry the identical deletion of a branch point in the IL-3 receptor alpha subunit gene. Blood 85: 2331-2336, 1995.
39. HATTERSLEY, G., J. OWENS, A. M. FLANAGAN, AND T. J. CHAMBERS. Mφ colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem. Biophys. Res. Commun. 177: 526-531, 1991.
40. HEANEY, M. L., AND D. W. GOLDE. Soluble hormone receptors. Blood 82: 1945-1948, 1993.
41. HOLNESS, C. L., R. P. DA SILVA, J. FAWCETT, S. GORDON, AND D. C. SIMMONS. Macrosialin, a mouse macrophage restricted glycoprotein, is a member of the lamp/lgp family. J. Biol. Chem. 268: 9661-9666, 1993.
42. HUANG, S., W. HENDRIKS, A. ALTHAGE, S. HEMMI, H. BLUETHMANN, R. KAMIJO, J. VILCEK, R. M. ZINKERNAGEL, AND M. AGUET. Immune response in mice that lack the interferon-γ receptor. Science Wash. DC 259: 1742-1745, 1993.
43. HUGHES, D. A., I. P. FRASER, AND S. GORDON. Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs. Eur. J. Immunol. 25: 466-473, 1995.
44. HUME, D. A., AND P. FAVOT. Is the osteopetrotic (op/op mutant) mouse completely deficient in expression of Mφ colony stimulating factor (CSF-1)? J. Interferon Cytokine Res. 15: 279-284, 1995.
45. HUME, D. A., A. P. ROBINSON, G. G. MACPHERSON, AND S. GORDON. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between Mφ, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J. Exp. Med. 158: 1532-1536, 1983.
46. IHLE, J. N., J. SILVER, AND C. A. KOZAK. Genetic mapping of the mouse interleukin 3 gene to chromosome 11. J. Immunol. 138: 3051-3054, 1987.
47. IHLE, J. N., AND Y. WEINSTEIN. Immunological regulation of hematopoietic/lymphoid stem cell differentiation by interleukin 3. Adv. Immunol. 39: 1-49, 1986.
48. INABA, K., M. INABA, N. ROMANI, H. AYA, M. DEGUCHI, S. IKEHARA, S. MURAMATSU, AND R. M. STEINMAN. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/Mφ colony stimulating factor. J. Exp. Med. 176: 1693-1702, 1992.
49. JOHNSON, R. A., B. F. BOYCE, G. R. MUNDY, AND G. D. ROODMAN. Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 124: 1424-1427, 1989.
50. JOHNSON, R. B., Jr. Monocytes and Mφ. N. Engl. J. Med. 318: 747-752, 1988.
51. JOHNSON, R. S., B. M. SPIEGELMAN, AND V. PAPAIOANNOU. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71: 577-586, 1992.
52. KACZMARSKI, R. S., AND G. J. MUFTI. The cytokine receptor superfamily. Blood Rev. 5: 193-203, 1991.
53. KALINSKI, P., E. URBANOWSKA, J. KAWIAK, G. HOSER, S. L. AUKERMAN, AND W. WIKTOR-JEDRZEJCZAK. CSF-1 dependent but not GM-CSF dependent Mφ recruit lymphocytes to peritoneal cavity (Abstract). Exp. Hematol. 21: 1014, 1993.
54. 3 on Mφ colony-stimulating factor production and proliferation of human monocytic cells. Blood 83: 2285-2293, 1994.
55. KAWASAKI, E. S., AND M. B. LADNER. Mφ-colony stimulating factor. In: Colony-Stimulating Factors. Molecular and Cellular Biology, edited by T. M. Dexter, J. M. Garland, and N. G. Testa. New York: Dekker, 1990, p. 155-176.
56. KINDRED, B. Deficient and sufficient immune systems in the nude mouse. In: Immunologic Defects in Laboratory Animals, edited by M. E. Gershwin and B. Merchant. New York: Plenum, 1981, vol. 1, p. 215-265.
57. KODAMA, T., M. FREEMAN, L. ROHRER, J. ZABRECKY, P. MATSUDAIRA, AND M. KRIEGER. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature Lond. 343: 531-535, 1990.
58. KODAMA, H., A. YAMASAKI, M. NOSE, S. NIJDA, Y. OHGAME, M. ABE, M. KUMEGAWA, AND T. SUDA. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of Mφ colony-stimulating factor. J. Exp. Med. 173: 269-272, 1991.
59. KOIKE, K., E. R. STANLEY, J. N. IHLE, AND M. OGAWA. Mφ colony formation supported by purified CSF-1 and/or interleukin 3 in serum-free culture: evidence for hierarchical difference in Mφ colony-forming cells. Blood 67: 859-864, 1986.
60. KOLLER, B. H., AND O. SMITHIES. Altering genes in animals by gene targeting. Annu. Rev. Immunol. 10: 705-730, 1992.
61. KOPF, M., H. BAUMANN, G. FREER, M. FREUDENBERG, M. LAMERS, T. KISHIMOTO, R. ZINKERNAGEL, H. BLUETHMANN, AND G. KOHLER. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature Lond. 368: 339-342, 1994.
62. KOPF, M., G. LEGROS, M. BACHMANN, M. C. LAMERS, H. BLUETHMANN, AND G. KOHLER. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature Lond. 362: 245-248, 1993.
63. KOVACS, E. J. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol. Today 12: 17-23, 1991.
64. KEIEGER, M., AND J. HERZ. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63: 601-637, 1994.
65. KRIEGLER, A. B., S. M. VERSHOOR, D. BERNARDO, AND I. BERTONCELLO. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow. Exp. Hematol. 22: 432-440, 1994.
66. KURIHARA, N., T. SUDA, Y. MIURA, H. NAKAUCHI, H. KODAMA, K. HIURA, Y. HAKEDA, AND M. KUMEGAWA. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 74: 1295-1302, 1989.
67. LANG, R. A., D. METCALF, R. A. CUTHBERTSON, I. LYONS, E. STANLEY, A. KELSO, G. KANNOURAMS, D. J. WILLIAMSON, G. K. KLINTWORTH, T. J. GONDA, AND A. R. DUNN. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of Mφ, blindness, and a fatal syndrome of tissue damage. Cell 51: 675-686, 1987.
68. LEE, M. Y., D. R. EYRE, AND W. R. A. OSBORNE. Isolation of a murine osteoclast colony-stimulating factor. Proc. Natl. Acad. Sci. USA 88: 8500-8503, 1991.
69. LEE, T. H., K. L. FEVOLD, Y. MUGURUMA, J. L. LOTTSFELDT, AND M. Y. LEE. Relative roles of osteoclast colony-stimulating factor and Mφ colony-stimulating factor in the course of osteoclast development. Exp. Hematol. 22: 66-73, 1994.
70. LIESCHKE, G. J., E. STANLEY, D. GRALL, G. HODGSON, V. SINICKAS, J. A. M. GALL, R. A. SINCLAIR, AND A. R. DUNN. Mice lacking both Mφ- and granulocyte-Mφ colony stimulating factor have Mφ and coexistent osteopetrosis and severe lung disease. Blood 84: 27-35, 1994.
71. LUOMA, J., T. HILTUNEN, T. SARKIOJA, S. K. MOESTRUP, J. GLIEMANN, T. KODAMA, T. NIKKARI, AND S. YLA-HERTTUALA. Expression of alpha2-macroglobulin receptor/low density lipoprotein-related protein and scavenger receptor in human atherosclerotic lesions. J. Clin. Invest. 93: 2014-2021, 1994.
72. MANTOVANI, A., B. BOTAZZI, F. COLOTTA, S. SOZZANI, AND L. RUCO. The origin and function of tumor-associated macrophages. Immunol. Today 13: 265-270, 1992.
73. MARKS, S. C., JR. Morphological evidence of reduced bone resorption in osteopetrotic (op) mice. Am. J. Anat. 163: 157-167, 1982.
74. MARKS, S. C., JR, Osteopetrosis: multiple patways for the interception of osteoclast function. Appl. Pathol. 5: 172-183, 1987.
75. MARKS, S. C., JR., AND P. W. LANE. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J. Hered. 67: 11-18, 1976.
76. MASSAGUE, J., AND A. PANDIELLA. Membrane-anchored growth factors. Annu. Rev. Biochem. 62: 515-541, 1993.
77. METCALF, D. Control of granulocytes and Mφ: molecular, cellular, and clinical aspects. Science Wash. DC 254: 529-533, 1991.
78. METCALF, D. Hematopoietic regulators: redundancy or subtlety? Blood 82: 3515-3523, 1993.
79. METCALF, D. The molecular control of normal and leukaemic granulocytes and Mφ. Proc. R. Soc. Biol. 230: 289-423, 1987.
80. METCALF, D., C. G. BEGLEY, D. J. WILLIAMSON, E. C. NICE, J. DELAMARTER, J. J. MERMOD, D. THATCHER, AND A. SCHMIDT. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp. Hematol. 15: 1-9, 1987.
81. METCALF, D., M. J. ELLIOTT, AND N. A. NICOLA. The excess numbers of peritoneal Mφ in granulocyte-Mφ colony-stimulating factor transgenic mice are generated by local proliferation. J. Exp. Med. 175: 877-884, 1992.
82. METCALF, D., S. MERCHAV, AND G. WAGEMAKER. Commitment by GM-CSF or M-CSF of bipotential GM progenitor cells to granulocyte or Mφ formation. In: Experimental Hematology Today 1982, edited by S. J. Baum, G. D. Ledney, and S. Thierfelder. Basel: Karger, 1982, p. 3-9.
83. METCALF, D., AND N. A. NICOLA. The clonal proliferation of normal mouse hematopoietic cells: enhancement and suppression by colony-stimulating factor combinations. Blood 79: 2861-2866, 1992.
84. MILHAUD, G., AND M. L. LABAT. Thymus and osteopetrosis. Clin. Orthop. 135: 260-271, 1978.
85. MIYAJIMA, A., T. KITAMURA, N. HARADA, T. YOKOTA, AND K-I. ARAI. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10: 295-331, 1992.
86. MORRIS, C. F., J. SALISBURY, M. KOBAYASHI, P. V. TOWNSEND, A. J. MOTOYOSHI, AND F. TAKAKU. Serum cholesterol-lowering activity of human monocytic colony-stimulating factor. Lancet ii: 326-327, 1989.
87. MORSE, B. S., D. GIULIANI, M. SOREMEKUN, S. DIFINO, AND E. R. GIULIANI. Adaptation of hemopoietic tissue resulting from estrone-induced osteosclerosis in mice. Cell Tissue Kinet. 7: 113-123, 1974.
88. MUNKER, R., J. GASSON, M. OGAWA, AND H. P. KOEFFLER. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature Lond. 323: 79-82, 1986.
89. NAITO, M., S.-I. HAYASHI, H. YOSHIDA, I. NISHIKAWA, L. D. SHULTZ, AND K. TAKAHASHI. Abnormal differentiation of tissue Mφ populations in "osteopetrosis" (op) mice defective in the production of Mφ colony-stimulating factor. Am. J. Pathol. 139: 657-667, 1991.
90. NAKASHIMA, Y., A. S. PLUMP, E. W. RAINES, J.-L. BRESLOW, AND R. ROSS. Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14: 133-140, 1994.
91. NAPEL, G. Interleukin 3 alone does not support the proliferation of bone marrow cells from A/J mice: a novel system for studying the synergistic activities of IL-3. Br. J. Haematol. 74: 131-137, 1990.
92. NILSSON, S. K., AND I. BERTONCELLO. Age-related changes in extramedullary hematopoiesis in the spleen of normal and perturbed osteopetrotic (op/op) mice. Exp. Hematol. 22: 377-383, 1994.
93. NILSSON, S. K., AND I. BERTONCELLO. The development and establishment of hemopoiesis in fetal and newborn osteopetrotic (op/ op) mice. Dev. Biol. 164: 456-462, 1994.
94. NILSSON, S. K., I. BERTONCELLO, H. CHEN, AND B. F. BOYCE. A systematic histomorphometric analysis of osteoclasts in the maturing osteopetrotic (op/op) mouse (Abstract). Exp. Hematol. 22: 810A, 1994.
95. NILSSON, S. K., G. J. LIESCHKE, C. C. GARCIA-WIJNEN, B. WILLIAMS, D. TZELEPIS, D. GRALL, A. R. DUNN, AND I. BERTONCELLO. Granulocyte-Mφ colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood 86: 66-72, 1995.
96. NOWICKI, A., J. SZENAJCH, G. OSTROWSKA, A. WOJTOWICZ, K. WOJTOWICZ, A. A. KRUSZEWSKI, M. MARUSZYNSKI, S. L. AUKERMAN, AND W. WIKTOR-JEDRZEJCZAK. Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int. J. Cancer 65: 112-119, 1996.
97. POLLARD, J. W., J. S. HUNT, W. WIKTOR-JEDRZEJCZAK, AND E. R. STANLEY. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev. Biol. 148: 273-283, 1991.
98. PRYSTOWSKY, M. B., G. OTTEN, M. F. NAUJOKAS, J. VARDIMAN, J. N. IHLE, E. GOLDWASSER, AND F. W. FITCH. Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3. Am. J. Pathol. 117: 171-179, 1984.
99. REES, R. C., AND H. PARRY. Mφ in tumour immunity. In: The Natural Immune System: The Mφ, edited by C. E. Lewis and J. O'D. McGee. Oxford, UK IRL, 1992, p. 316-357.
100. ROSS, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature Lond. 362: 801-809 1993.
101. RUTHERFORD, M. S., S. WITSELL, AND L. B. SCHOOK. Mechanisms generating functionally heterogeneous Mφ: chaos revisited. J. Leukocyte Biol. 53: 602-618, 1993.
102. SCHAUB, R. G., L. H. DONNELLY, T. S. PARKER, S. K. CLINTON, AND M. B. GARNICK. The protective role of the macrophage in atherogenesis: insight from using M-CSF. In: Atherosclerosis X, edited by F. P. Woodford, J. Davignon, and A. Sniderman. Montreal, Canada: Elsevier Science, 1995, p. 537-544.
103. SCHORLE, H., T. HOLTSCHKE, T. HUNIG, A. SCHIMPL, AND I. HORAK. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature Lond. 352: 621-624, 1991.
104. SCOTT, E. W., M. C. SIMON, J. ANASTASI, AND H. SINGH. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science Wash. DC 265: 1573-1577, 1994.
105. SHERR, C. J., G. V. BORZILLO, J.-Y. KATO, S. A. SHURTLEFF, J. R. DOWNING, AND M. F. ROUSSEL. Regulation of cell growth and differentiation by the colony-stimulating factor 1 receptor. Semin. Hematol. 28: 143-151, 1991.
106. 2. Blood 83: 3316-3323, 1994.
107. d. J. Immunol. 135: 3905-3910, 1985.
108. SHY, Y.-J., L. L. WICKHAM, J. P. HAGAN, H.-J. HSIEH, Y.-L. HU, S. H. TELIAN, A. J. VALENTE, K.-L. P. SUNG, AND S. CHIEN. Human monocyte colony-stimulating factor stimulates the gene expression of monocyte chemotactic protein-1 and increases the adhesion of monocytes to endothelial monolayers. J. Clin. Invest. 92: 1745-1751, 1993.
109. SLUITER, W., E. HULSING-HESSELINK, I. ELZENGA-CLAASEN, L. W. M. VANHEMSBERGEN-OOMENS, A. VANDERVOORTVANDERKLEIJ-VANANDEL, AND R. VAN FURTH. Mφ as origin of factor increasing monocytopoiesis. J. Exp. Med. 166: 909-922, 1987.
110. SMITH, J. D., E. TROGAN, M. GINSBERG, C. GRIGAUX, J. TIAU, AND M. MIYATA. Decreased atherosclerosis in mice deficient in both CSF (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92: 8264-8268, 1995.
111. SORIANO, P., C. MONTGOMERY, R. GESKE, AND A. BRADLEY. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702, 1991.
112. STANLEY, E., G. J. LIESCHKE, D. GRAIL, D. METCALF, G. HODGSON, J. A. M. GALL, D. W. MAHER, J. CEBON, V. SINICKAS, AND A. R. DUNN. Granulocyte/Mφ colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91: 5592-5596, 1994.
113. STANLEY, E. R. Colony stimulating factor-1 (Mφ colony stimulating factor). In: The Cytokine Handbook. New York: Academic, 1994, p. 387-418.
114. STANLEY, E. R., A. BARTOCCI, D. PATINKIN, M. ROSENDAAL, AND T. R. BRADLEY. Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1. Cell 45: 667-674, 1986.
115. STEINMAN, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296, 1991.
116. SUDA, T., J. SUDA, AND M. OGAWA. Single-cell origin of mouse hemopoietic colonies expressing multiple lineages in variable combinations. Proc. Natl. Acad. Sci. USA 80: 6689-6693, 1983.
117. SUDA, T., J. SUDA, AND M. OGAWA. Disparate differentiation in mouse hemopoietic colonies derived from paired progenitors. Proc. Natl. Acad. Sci. USA 81: 2520-2524, 1984.
118. SUDA, T., N. TAKAHASHI, AND E. ABE. Role of vitamin D in bone resorption. J. Cell. Biochem. 49: 53-58, 1992.
119. SUNDERKOTTER, C., K. STEINBRINK, M. GOEBELER, R. BHARDWAJ, AND C. SORG. Mφ and angiogenesis. J. Leukocyte Biol. 55: 410-422, 1994.
120. SUNDQUIST, K. T., M. G. CECCHINI, AND S. C. MARKS, JR. Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice. Bone 16: 39-46, 1995.
121. SZPERL, M., A. A. ANSARI, E. URBANOWSKA, P. SZWECH, P. KALINSKI, AND W. WIKTOR-JEDRZEJCZAK. Increased resistance of CSF-1-deficient, Mφ-deflcient, TNFα-deficient, and IL-1α-deficient op/op mice to endotoxin. Ann. NY Acad. Sci. 762: 499-501, 1995.
122. TAGA, T., AND T. KISHIMOTO. Cytokine receptors and signal transduction. FASEB J. 6: 3387-3396, 1992.
123. TAKAHASHI, K., M. NAITO, AND L. D. SHULTZ. Differentiation of epidermal Langerhans cells in Mφ colony-stimulating-factor-deficient mice homozygous for the osteopetrosis (op) mutation. J. Invest. Dermatol. 99, Suppl.: 46S-47S, 1992.
124. TAKAHASHI, K., M. NAITO, L. D. SHULTZ, S.-I. HAYASHI, AND S.-I. NISHIKAWA. Differentiation of dendritic cell populations in Mφ colony-stimulating factor deficient mice homozygous for the osteopetrosis (op) mutation. J. Leukocyte Biol. 53: 19-28, 1993.
125. TAKAHASHI, K., M. NAITO, S. UMEDA, AND L. D. SHULTZ. The role of Mφ colony-stimulating factor in hepatic glucan-induced granuloma formation in the osteopetrosis mutant mouse defective in the production of Mφ colony-stimulating factor. Am. J. Pathol. 144: 1381-1392, 1994.
126. TEMELES, D. S., H. E. MCGRATH, E. L. W. KITTLER, R. K. SHADDUCK, V. K. KISTER, R. B. CRITTENDEN, B. L. TURNER, AND P. J. QUESENBERRY. Cytokine expression from bone marrow derived Mφ. Exp. Hematol. 21: 388-393, 1993.
127. TRAVIS, J. Scoring a technical knockout in mice. Science Wash. DC 256: 1392-1394, 1992.
128. TUSHINSKI, R. J., I. T. OLIVER, L. J. GUILBERT, P. W. TYNAN, J. R. WARNER, AND E. R. STANLEY. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28: 71-81, 1982.
129. VAIRO, G., AND J. A. HAMILTON. Signalling through CSF receptors. Immunol. Today 12: 363-369, 1991.
130. VAN FURTH, R. Cell biology of mononuclear phagocytes. In: Hemopoietic Growth Factors and Mononuclear Phagocytes, edited by R. VanFurth. Basel: Karger, 1993, p. 1-9.
131. VAN FURTH, R., Z. A. COHN, J. G. HIRSCH, J. H. HUMPHREY, W. G. SPECTOR, AND H. L. LANGEVOORT. The mononuclear phagocyte system. A new classification of Mφ, monocytes, and their precursor cells. Bull. WHO 46: 845-852, 1972.
132. VASSALLI, P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10: 411-452, 1992.
133. VOGEL, S. N., A. C WEINBLATT, AND D. L. ROSENSTREICH. Inherent Mφ defects in mice. In: Immunologic Defects in Laboratory Animals, edited by M. E. Gershwin and B. Merchant. New York: Plenum, 1991, p. 327-357.
134. WANG, Z.-Q., C. OVITT, A. E. GRIGORIADIS, U. MOHLE-STEINLEIN, U. RUTHER, AND E. F. WAGNER. Bone and haematopoietic defects in mice lacking c-fos. Nature Lond. 360: 741-745, 1992.
135. WHETTON, A. D., AND T. M. DEXTER. Myeloid haemopoietic growth factors. Biochim. Biophys. Acta 989: 111-132, 1989.
136. WIFFEILS, J. F. A. M., Z. DEROVER, G. KRAAL, AND R. H. J. BEELEN. Mφ phenotype regulation by colony-stimulating factors at bone marrow level. J. Leukocyte Biol. 53: 249-255, 1993.
137. WIKTOR-JEDRZEJCZAK, W. Cure of osteopetrosis in op/op mice by bone grinding and good food? Exp. Hematol. 21: 1314-1315, 1993.
138. WIKTOR-JEDRZEJCZAK, W. In vivo role of Mφ growth factors as delineated using CSF-1 deficient op/op mouse. Leukemia 7, Suppl.: S117-S121, 1993.
139. WIKTOR-JEDRZEJCZAK, W., A. AHMED, R. SKELLY, C. SZCZYLIK, AND P. GORNAS. Mφ defect in genetically osteopetrotic op/op mouse is due to the insufficient production of colony stimulating activity (CSA) by hemopoietic stromal fibroblastoid cells (Abstract). Exp. Hematol. 8: 133A, 1980.
140. WIKTOR-JEDRZEJCZAK, W., A. AHMED, C. SZCZYLIK, AND R. R. SKELLY. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal Mφ differentiation. J. Exp. Med. 156: 1516-1527, 1982.
141. WIKTOR-JEDRZEJCZAK, W., A. AHMED-ANSARI, AND K. W. SELL. In vivo role of hemopoietic growth factors as delineated using congenitally Mφ/osteoclast deficient op/op mice (Abstract). Exp. Hematol. 17: 703A, 1989.
142. WIKTOR-JEDRZEJCZAK, W., A. A. ANSARI, M. SZPERL, AND E. URBANOWSKA. Distinct in vivo functions of two Mφ subpopulations as evidenced by studies using Mφ-deficient op/op mouse. Eur. J. Immunol. 22: 1951-1954, 1992.
143. WIKTOR-JEDRZEJCZAK, W., A. BARTOCCI, A. W. FERRANTE, JR., A. AHMED-ANSARI, K. W. SELL, J. W. POLLARD, AND E. R. STANLEY. Total absence of colony-stimulating factor 1 in the Mφ-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA 87: 4828-4832, 1990.
144. WIKTOR-JEDRZEJCZAK, W., B. DZWIGALA, M. SZPERL, M. MARUSZYNSKI, E. URBANOWSKA, AND P. SZWECH. Colony stimulating factor-1 (CSF-1)-dependent resident macrophages play regulatory role in fighting Escherichia coli fecal peritonitis as determined using CSF-1 deficient op/op mouse. Infect. Immun. In press.
145. WIKTOR-JEDRZEJCZAK, W., A. NOWICKI, G. OSTROWSKA, S. L. AUKERMAN, J. KUROPATWA, AND A. KRUSZEWSKI. Impaired tumor growth in CSF-1 deficient, Mφ-deficient op/op mouse (Abstract). Exp. Hematol. 22: 770A, 1994.
146. WIKTOR-JEDRZEJCZAK, W., M. Z. RATAJCZAK, A. PTASZNIK, K. W. SELL, A. AHMED-ANSARI, AND W. OSTERTAG. CSF-1 deficiency in the op/op mouse has differential effects on Mφ populations and differentiation stages. Exp. Hematol. 20: 1004-1010, 1992.
147. WIKTOR-JEDRZEJCZAK, W., K. W. SELL, P. SZWECH, AND A. AHMED-ANSARI. Absence of CSF-1 in macrophage-deficient op/ op mice has differential effects on macrophage colony stimulating activity (M-CSA) released by various organs and cells. Folia Histochem. Cytobiol. 33: 259-265, 1995.
148. WIKTOR-JEDRZEJCZAK, W., S. J. SHARKIS, A. AHMED, K. W. SELL, AND G. W. SANTOS. Theta-sensitive cell and erythropoiesis: identification of a defect in HW anemic mice. Science Wash. DC 196: 313-315, 1977.
149. WIKTOR-JEDRZEJCZAK, W., R. R. SKELLY, AND A. AHMED. Hematopoietic stem cell differentiation and its role in osteopetrosis. Immunologic implications. In: Immunologic Defects in Laboratory Animals, edited by M. E. Gerschwin and B. Merchant. New York: Plenum, 1981, vol. 1, p. 51-77.
150. WIKTOR-JEDRZEJCZAK, W., E. URBANOWSKA, S. L. AUKERMAN, J. W. POLLARD, E. R. STANLEY, P. RALPH, A. A. ANSARI, K. W. SELL, AND M. SZPERL. Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp. Hematol. 19: 1049-1054, 1991.
151. WIKTOR-JEDRZEJCZAK, W., E. URBANOWSKA, AND M. SZPERL. Granulocyte-Mφ colony-stimulating factor corrects Mφ deficiences, but not osteopetrosis in the colony-stimulating factor-1-deficient op/op mouse. Endocrinology 134: 1932-1935, 1994.
152. WIKTOR-JEDRZEJCZAK, W., E. URBANOWSKA, M. SZPERL, P. KALINSKI, B. MATA, S. L. AUKERMAN, AND J. KUROPATWA. Essential in vivo role for CSF-1 in stimulating bone resorption confirmed by partial resolution of osteopetroses not due to the absence of this growth factor (Abstract). Exp. Hematol. 21: 1170, 1993.
153. WINK, C. S., D. F. SARPONG, AND R. D. BRUCK. Tibial dimensions before and during the recovery phase in the osteopetrotic mutant mice. Acte Anat. 141: 174-181, 1991.
154. WITMER-PACK, M. D., D. A. HUGHES, G. SCHULER, L. LAWSON, A. MCWILLIAM, K. INABA, R. M. STEINMAN, AND S. GORDON. Identification of Mφ and dendritic cells in the osteopetrotic (op/ op) mouse. J. Cell Sci. 104: 1021-1029, 1993.
155. WITSELL, A. L., AND L. B. SCHOOK. Mφ heterogeneity occurs through a developmental mechanism. Proc. Natl. Acad. Sci. USA 88: 1963-1967, 1991.
156. WITSELL, A. L., AND L. B. SCHOOK. Tumor necrosis factor a is an autocrine growth regulator during Mφ differentiation. Proc. Natl. Acad. Sci. USA 89: 4754-4758, 1992.
157. WITTE, O. N. Steel locus defines new multipotent growth factor. Cell 63: 5-6, 1990.
158. YOSHIDA, H., I. HAYASHI, T. KUNISADA, M. OGAWA, S. NISHIKAWA, H. OKAMURA, T. SUDO, D. SHULTZ, AND S.-I. NISHIKAWA. The murine mutation osteopetrosis is in the coding region of the Mφ colony stimulating factor gene. Nature Lond. 345: 442-444, 1990.